Bioheart's Series D Round

Bioheart raised a round of funding on September 07, 2005.

Bioheart is a biotechnology company focused on the discovery, development, and commercialization of cell therapies for the treatment of chronic and acute heart damage.…

Articles about Bioheart's Series D Round: